Blockbuster weight loss drugs Wegovy and Ozempic are being tested to treat addiction and dementia
Publishing timestamp: 2023-09-07 01:29:09
Summary
Scientists are investigating whether obesity drugs can be used to treat conditions such as dementia and alcohol addiction. Recent trials have shown that these drugs can reduce heart failure-related symptoms and major cardiovascular events. Pharmaceutical companies like Novo Nordisk and Eli Lilly are seeking to broaden the applications of these drugs beyond weight loss. Researchers are hopeful that these drugs can be effective in treating other conditions such as drug and alcohol addiction, dementia, and polycystic ovary syndrome. However, there are concerns about high costs, supply shortages, and possible adverse effects of the drugs. Further research is needed to understand the impact of these drugs on the brain's reward signaling system.
Sentiment: POSITIVE
Keywords: novo nordisk a/s, business news, pharmaceuticals, science, eli lilly and co, health care industry, biotech and pharmaceuticals,